Dr. Marzena Skrzypczak-Zielinska is graduate of biotechnology at the University of Life Sciences in Poznan. After graduating, she was seven months internship within Leonardo da Vinci Programm in the Institute of Human Genetics at the University of Leipzig. Subsequently, she started in Germany at the University of Leipzig the PhD study and after four years she received the Doctor title. Research in this period concern the development of new methods for the detection of dynamic mutations in the neurodegenerative diseases. In January 2009, Dr. Skrzypczak-Zielinska started scientific work at the Institute of Human Genetics Polish Academy of Sciences in the Department of Nucleic Acids Function under supervision of Prof. R. Słomski. Her research interest relate mainly to the molecular aspects determining the occurrence, course and treatment of inflammatory bowel diseases and studies in the field of pharmacogenetics in anesthesia and pain management. Membership in organizations: member of the Polish Society of Human Genetics, of the College of Laboratory Medicine in Poland and of the National Association of Laboratory Diagnosticians.
dr hab. n. med. i n. o zdr. Marzena Skrzypczak-Zielińska
Publications
Are variants of the RBP4 gene associated with serum retinol-binding protein 4 concentrations and carotid intima-media thickness values in women with obesity?
Rychter AM, Skrzypczak-Zielińska M, Naskręt D, Michalak M, Zawada A, Walczak M, Słomski R, Dobrowolska A, Krela-Kaźmierczak I
Gene, 2024, 893: 147909, 8 str.; 147909. doi: 10.1016/j.gene.2023.147909. Epub 2023 Oct 17IF-3.5 MNiSW-70
Variants of the CASP9 gene as candidate markers for primary response to anti-TNF therapy in Crohn's disease patients.
Lykowska-Szuber L, Walczak M, Stawczyk-Eder K, Krela-Kazmierczak I, Eder P, Zakerska-Banaszak O, Dobrowolska A, Skrzypczak-Zielinska M
J Appl Genet, 2023 Dec, 64 (4): 759-88, doi: 10.1007/s13353-023-00783-7, Epub Sep 2IF-2.4 MNiSW-140
Association of the ILR1 and FAS genes variants with a primary non-response to anti-TNF therapy in Crohn’s disease patients.
Łykowska-Szuber L, Skrzypczak-Zielińska M, Żuraszek J, Walczak M, Stawczy-Eder K, Krela-Kaźmierczak I, Michalak M, Słomski R, Dobrowolska A
Pol Arch Intern Med, 2023, March 14, 16461, doi: 10.20452/pamw.16461IF-4.8 MNiSW-200
Apoptosis and inflammatory genes variants in primary non-response to anti-TNF therapy in Crohn's disease patients.
Łykowska-Szuber L, Walczak M, Dobrowolska A, Skrzypczak-Zielińska M
Eur J Gastroenterol Hepatol, 2023, 35 (10): 1088-96. doi: 10.1097/MEG.0000000000002618. Epub Jul 31IF-2.1 MNiSW-40
Alterations in Gut Microbiota Composition in Patients with Covid-19: A pilot Study of whole Hypervariable 16S rRNA Gene Sequencing.
Mańkowska-Wierzbicka D, Żuraszek J, Wierzbicka A, Gabryel M, Mahadea D, Baturo A, Zakerska-Banaszak O, Słomski R, Skrzypczak-Zielińska M, Dobrowolska A
Biomedicines (MDPI), 2023, Jan 27; 11 (2): 367, 16 str; doi: 10.3390/biomedicines11020367IF-4.7 MNiSW-100
Does the VDR gene polymorphism influence the efficacy of denosumab therapy in postmenopausal osteoporosis?
Wawrzyniak A, Skrzypczak-Zielińska M, Michalak M, Kaczmarek-Ryś M, Ratajczak AE, Rychter AM, Skoracka K, Marcinkowska M, Słomski R, Dobrowolska A, Krela-Kaźmierczak I
Front Endocrinol (Lausanne), 2023, Jan 13, 13: 1063762, doi: 10.3389/fendo.2022.1063762.eCollection 2022IF-5.2 MNiSW-100
Where Do We Stand in the Behavioral Pathogenesis of Inflammatory Bowel Disease? The Western Dietary Pattern and Microbiota—A Narrative Review.
Krela-Kaźmierczak I, Zakerska-Banaszak O, Skrzypczak-Zielińska M, Łykowska-Szuber L, Szymczak-Tomczak A, Zawada A, Rychter AM, Ratajczak AE, Skoracka K, Skrzypczak D, Marcinkowska E, Słomski R, Dobrowolska A
Nutrients (MDPI), 2022, 14 (12), 252, 28 str, doi/10.3390/nu14122520IF-5,719 MNiSW-140
Cytotoxicity of thiopurine drugs in patients with inflammatory bowel disease.
Zakerska-Banaszak O, Łykowska-Szuber L, Walczak M, Żuraszek J, Zielińska A, Skrzypczak-Zielińska M
Toxic, 2022, 10 (4), 151, 19 stron, doi/10.3390/toxics1004015IF-4,146 MNiSW-70
Next-generation sequencing analysis in male infertility diagnostics.
Skrzypczak-Zielińska M, Frączek M
Postępy Andrologii online, 2021, 8 (2): 6-15
Myostatin and Follistatin—New Kids on the Block in the Diagnosis of Sarcopenia in IBD and Possible Therapeutic Implications.
Skrzypczak D, Skrzypczak-Zielińska M, Ratajczak AE, Szymczak-Tomczak A, Eder P, Słomski R, Dobrowolska A, Krela-Kaźmierczak I
Biomedicines (MDPI), 2021, 9 (10), 12 str, 1301. doi.10.3390/biomedicines9101301IF-6,081 MNiSW-20
All publications
Events
13-16.01.2015 Where:
Krakow, Poland
XXXII Winter School, Pharmacology of cannabinoids
9-10.10.2014 Where:
Poznan, Poland
Scientific Conference, DNA analysis – practice
8 – 11.06.2013 Where:
Paris, France
The European Human Genetics Conference 2013
27-28.11.2012 Where:
Poznan, Poland
Conference Genes and Drugs. I Polish Congress of Pharmacogenetics
23–26.06.2012 Where:
Nürnberg, Germany
The European Human Genetics Conference 2012
12-15.06.2010 Where:
Gothenburg, Sweden
The European Human Genetics Conference 2010
23-26.05.2009 Where:
Vienna, Austria
The European Human Genetics Conference 2009
31.05-03.06.2008 Where:
Barcelona, Spain
The European Human Genetics Conference 2008
16-19.06.2007 Where:
Nice, France
The European Human Genetics Conference 2007
Awards
dr n. roln. Oliwia Zakerska-Banaszak
dr hab. n. med. i n. o zdr. Marzena Skrzypczak-Zielińska
prof. dr hab. n. med. Ryszard Słomski
Biocodex award
Award in the competition 'Microbiota in health and disease' for funding a research project entitled "Treatment of patients with irritable bowel syndrome (IBS) by means of intestinal microbiota transplantation - evaluation of the therapy and its effect on the change of the intestinal microbiome". Manager dr Marcin Gabryel.